AT
MDT icon

Arvest Trust’s Medtronic MDT Stock Holding History

Arvest Trust’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2,276
Closed -$204K – 182
2022
Q2 		$204K Buy
2,276
+233
+11% +$23.6K 0.01% 146
2022
Q1 		$227K Sell
2,043
-341
-14% -$36K 0.01% 158
2021
Q4 		$247K Buy
+2,384
New +$276K 0.01% 153

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Arvest Trust's MDT Position: Q3 2022 in Review

Arvest Trust sold out of Medtronic (MDT) in Q3 2022, closing a stake of 2,276 shares — an estimated $204K sold.

Arvest Trust first reported a position in MDT in Q4 2021 and held it in 3 quarters. The position peaked at $247K in Q4 2021. 1,932 funds tracked by Wall St. Rank hold MDT as of Q3 2022.

  • Arvest Trust reported no remaining Medtronic position as of Q3 2022 after selling out during the quarter.
  • Arvest Trust sold 2,276 Medtronic shares in Q3 2022, an estimated $204K.
  • Arvest Trust first reported a position in Medtronic in Q4 2021 and held it in 3 quarters.
  • Arvest Trust's Medtronic position peaked at $247K in Q4 2021.
  • 1,932 funds tracked by Wall St. Rank held Medtronic as of Q3 2022.

Based on Arvest Trust's 13F filing for Q3 2022, filed 7 Nov 2022.